Search

Your search keyword '"Coleman, Ryan D."' showing total 42 results
Start Over Author "Coleman, Ryan D."
42 results on '"Coleman, Ryan D."'

1. Use of Berlin EXCOR cannulas in both venovenous and venoarterial central extracorporeal membrane oxygenation configurations overcomes the problem of cannula instability while bridging infants and young children to lung transplant

Author

Stephens, N. Adam, Chartan, Corey A., Gazzaneo, Maria C., Thomas, James A., Das, Shailendra, Mallory, George B., Jr., Melicoff, Ernestina, Vogel, Adam M., Parker, Amanda, Hermes, Emily, Heinle, Jeffrey S., McKenzie, E. Dean, and Coleman, Ryan D.

Published
2023
Full Text
View/download PDF

4. Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension

Author

Magness, S. Melissa, Anderson, Venus R., Mullen, Mary M., Gorbachevsky, Sergey V., Zaets, Sergey B., Haarman, Meindina G., Szezepanski, Isabelle, Grady, R. Mark, Canter, Matthew W., Wan, Fei, Shmalts, Anton A., Coleman, Ryan D., Beghetti, Maurice, Berger, Rolf M.F., del Cerro Marin, Maria J., Fletcher, Scott E., Hirsch, Russel, Humpl, Tilman, Ivy, D. Dunbar, Kirkpatrick, Edward C., Kulik, Thomas J., Levy, Marilyne, Moledina, Shahin, Yung, Delphine, Eghtesady, Pirooz, and Bonnet, Damien

Published
2021
Full Text
View/download PDF

8. Atrial septal defect closure is associated with improved clinical status in patients ≤ 10 kg with bronchopulmonary dysplasia

Author

Webb, Melissa K., primary, Cuevas Guaman, Milenka, additional, Sexson Tejtel, S. Kristen, additional, Cambronero, Neil, additional, Coleman, Ryan D., additional, Chartan, Corey A., additional, Yilmaz Furtun, Betul, additional, Morris, Shaine A., additional, Varghese, Nidhy P., additional, and Villafranco, Natalie M., additional

Published
2023
Full Text
View/download PDF

16. Characterization of Suboptimal Responses to Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia

Author

Espinoza, Jimmy, primary, King, Alice, additional, Shamshirsaz, Alireza A., additional, Nassr, Ahmed A., additional, Donepudi, Roopali, additional, Sanz Cortes, Magdalena, additional, Meholin-Ray, Amy R., additional, Krispin, Eyal, additional, Johnson, Rebecca, additional, Mendez Martinez, Yamely, additional, Keswani, Sundeep G., additional, Lee, Timothy C., additional, Joyeux, Luc, additional, Espinoza, Andres F., additional, Olutoye II, Oluyinka, additional, Garcia-Prats, Joseph A., additional, Fernandes, Caraciolo J., additional, Coleman, Ryan D., additional, Lohmann, Pablo, additional, Rhee, Christopher J., additional, Davies, Jonathan, additional, and Belfort, Michael A., additional

Published
2023
Full Text
View/download PDF

22. Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension

Author

Grady, R. Mark, primary, Canter, Matthew W., additional, Wan, Fei, additional, Shmalts, Anton A., additional, Coleman, Ryan D., additional, Beghetti, Maurice, additional, Berger, Rolf M.F., additional, del Cerro Marin, Maria J., additional, Fletcher, Scott E., additional, Hirsch, Russel, additional, Humpl, Tilman, additional, Ivy, D. Dunbar, additional, Kirkpatrick, Edward C., additional, Kulik, Thomas J., additional, Levy, Marilyne, additional, Moledina, Shahin, additional, Yung, Delphine, additional, Eghtesady, Pirooz, additional, Bonnet, Damien, additional, Magness, S. Melissa, additional, Anderson, Venus R., additional, Mullen, Mary M., additional, Gorbachevsky, Sergey V., additional, Zaets, Sergey B., additional, Haarman, Meindina G., additional, and Szezepanski, Isabelle, additional

Published
2021
Full Text
View/download PDF

31. Safely repositioning dual-lumen ECMO cannulas with a transfemoral lasso snare.

Author

O'Neil, Erika R, Coleman, Ryan D, Vogel, Adam M, Chartan, Corey A, and Kukreja, Kamlesh U

Subjects
*SAFETY, *ECHOCARDIOGRAPHY, *HUMAN research subjects, *ULTRASONIC imaging, *HEMATOMA, *EXTRACORPOREAL membrane oxygenation, *OXYGEN saturation, *INFORMED consent (Medical law), *FLUOROSCOPY, *TREATMENT effectiveness, *JUGULAR vein, *DESCRIPTIVE statistics, *CATHETERIZATION, *CATHETERS, *HEMORRHAGE, *CHILDREN
Abstract

Introduction: Dual-lumen cannulas were designed to provide venovenous extracorporeal membrane oxygenation (VV ECMO) with single-vessel access. Anatomic and size considerations may make appropriate placement challenging in children. Dual-lumen cannulas are repositioned in 20–69% of pediatric patients, which can be difficult without transient discontinuation of ECMO support. Methods: We repositioned three dual-lumen ECMO cannulas introduced via the right internal jugular vein using a transfemoral snare technique under real-time ultrasound and fluoroscopy. Results: Two of three patients were supported on VV ECMO and one on veno-veno-arterial (VV-A) ECMO. Two of the three patients had their dual-lumen cannula repositioned under ultrasound and fluoroscopy guidance and one was repositioned just with ultrasound. No patient experienced a complication from the transfemoral snare technique such as femoral hematoma, hemorrhage or limb ischemia. Conclusion: We describe three patients who successfully had dual-lumen cannulas repositioned without cessation of ECMO using a transfemoral "lasso" technique. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

32. Extracorporeal Membrane Oxygenation Support for Antineutrophil Cytoplasmic Antibody-associated Vasculitides: An ELSO Registry Analysis

Author

O’Neil, Erika R., Quinn, Rachel E., Olson, Taylor L., Rycus, Peter T., Anders, Marc M., Chartan, Corey A., Vogel, Tiphanie P., Silva-Carmona, Manuel, and Coleman, Ryan D.

Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides with pulmonary involvement include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis, and can present with life-threatening pulmonary hemorrhage in up to 40% of patients. Mortality in those patients who require intubation and mechanical ventilation can reach 77%. Extracorporeal membrane oxygenation (ECMO) can be used to support these patients through definitive diagnosis and treatment, although minimizing the risk of ventilator-induced lung injury. We aimed to determine factors associated with favorable outcomes in patients with (ANCA)-associated vasculitides supported on ECMO. We performed a retrospective observational study using the Extracorporeal Life Support Organization registry of pediatric and adult patients with ANCA-associated vasculitis supported on ECMO from 2010 to 2020. One hundred thirty-five patients were included for analysis. Many patients had renal involvement (39%) in addition to pulmonary involvement (93%). Survival was 73% in AAV patients supported on ECMO. The presence of pulmonary hemorrhage was not associated with worse outcomes in our cohort. Older age, the use of venoarterial ECMO, ECMO-cardiopulmonary resuscitation, or sustaining a cardiac arrest before ECMO was associated with decreased survival. In conclusion, venovenous ECMO should be considered as a supportive bridge to definitive diagnosis and treatment in (ANCA)-associated vasculitides, regardless if pulmonary hemorrhage is present.

Published
2022
Full Text
View/download PDF

35. Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: The PEDECOR experience.

Author

Steppan, Diana A., Coleman, Ryan D., Viamonte, Heather K., Hanson, Sheila J., Carroll, Megan K., Klein, Orly R., Cooke, Kenneth R., Spinella, Philip C., Steiner, Marie E., Loftis, Laura L., Bembea, Melania M., and Pediatric ECMO (PediECMO) subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Extracorporeal Life Support Organization (ELSO)

Published
2020
Full Text
View/download PDF

37. Synthetic Cannabinoid Exposure

Author

Adair, Austin, primary, Greene, Spencer C., additional, Greeley, Christopher S., additional, Coleman, Ryan D., additional, and Shekerdemian, Lara S., additional

Published
2016
Full Text
View/download PDF

40. Short-term neurologic outcomes in pediatric extracorporeal membrane oxygenation are proportional to bleeding severity graded by a novel bleeding scale.

Author

Doane, Katherine, Guffey, Danielle, Loftis, Laura L, Nguyen, Trung C, Musick, Matthew A, Ruth, Amanda, Coleman, Ryan D, Teruya, Jun, Allen, Christine, Bembea, Melania M, Boville, Brian, Furlong-Dillard, Jamie, Kaipa, Santosh, Leimanis, Mara, Malone, Matthew P, Rasmussen, Lindsey K, Said, Ahmed, Steiner, Marie E, Tzanetos, Deanna T, and Viamonte, Heather

Subjects
*EXTRACORPOREAL membrane oxygenation, *LOGISTIC regression analysis, *ACUTE kidney failure, *CARDIOPULMONARY resuscitation, *HOSPITAL admission & discharge
Abstract

This study aimed to characterize the severity of bleeding and its association with short-term neurologic outcomes in pediatric ECMO.Multicenter retrospective cohort study of pediatric ECMO patients at 10 centers utilizing the Pediatric ECMO Outcomes Registry (PEDECOR) database from December 2013-February 2019. Subjects excluded were post-cardiac surgery patients and those with neonatal pathologies. A novel ECMO bleeding scale was utilized to categorize daily bleeding events. Poor short-term neurologic outcome was defined as an unfavorable Pediatric Cerebral Performance Category (PCPC) or Pediatric Overall Performance Category (POPC) (score of >3) at hospital discharge.This study included 283 pediatric ECMO patients with a median (interquartile range [IQR]) age of 1.3 years [0.1, 9.0], ECMO duration of 5 days [3.0, 9.5], and 44.1% mortality. Unfavorable PCPC and POPC were observed in 48.4% and 51.3% of patients at discharge, respectively. Multivariable logistic regression analysis included patient’s age, cannulation type, duration of ECMO, need for cardiopulmonary resuscitation, acute kidney injury, new infection, and vasoactive-inotropic score. As the severity of bleeding increased, there was a corresponding increase in the likelihood of poor neurologic recovery, shown by increasing odds of unfavorable neurologic outcome (PCPC), with an adjusted odds ratio (aOR) of 0.77 (confidence interval [CI] 0.36–1.62), 1.87 (0.54–6.45), 2.97 (1.32–6.69), and 5.56 (0.59–52.25) for increasing bleeding severity (grade 1 to 4 events, respectively). Similarly, unfavorable POPC aOR (CI) was 1.02 (0.48–2.17), 2.05 (0.63–6.70), 5.29 (2.12–13.23), and 5.11 (0.66–39.64) for bleeding grade 1 to 4 events.Short-term neurologic outcomes in pediatric ECMO are proportional to the severity of bleeding events. Strategies to mitigate bleeding events could improve neurologic recovery in pediatric ECMO. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy. An Official American Thoracic Society Clinical Practice Guideline.

Author

Hayes D Jr, Jennerich AL, Coleman RD, Abston E, Adamson GT, Berger JT, Cohen SP, Cooper DS, Eghtesady P, Fynn-Thompson F, Grady RM, Hon SM, Hoopes CW, Jewell T, Lewthwaite H, Liu MF, McGiffin DC, Mullen MP, Qureshi AM, and Morales DLS

Abstract

Background: Pulmonary hypertension in children often progresses despite optimal therapy. This document provides an evidence-based clinical practice guideline for the management of children with progressive pulmonary hypertension despite optimal therapy., Methods: A multidisciplinary panel identified pertinent questions regarding the management of children with pulmonary hypertension that has progressed despite optimal therapy, conducted systematic reviews of the relevant literature, and applied the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to develop clinical recommendations., Results: After reviewing the research evidence, the panel considered the balance of desirable (benefits) and undesirable (harms and burdens) effects of the interventions in each proposed question. Valuation of our main outcomes was also considered, along with resources required, equity, acceptability, and feasibility. Recommendations were developed for or against interventional strategies specific to children with pulmonary hypertension that has progressed despite optimal therapy., Conclusions: Although there is a growing population of children with pulmonary hypertension, there is a striking lack of empirical evidence regarding management of those whose disease has progressed despite optimal pharmacotherapy. The panel formulated and provided the rationale for clinical recommendations for or against interventional strategies based on this limited empirical evidence, coupled with expert opinion, to aid clinicians in the management of these complex pediatric patients. In addition, we identified important areas for future research.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results